 GlyTI-M is an endogenous Glycine transporter I inhibitor, and it acts on the glutamatergic synapse to modulate the neurotransmission of N-Methyl-D-Aspertate NMDA receptor. This study aims to explore the effect of GlyTI-M among children with ADHD. 